FDA applicant
Syncthink, Inc.
FDA records 2 decisions for Syncthink, Inc. (Palo Alto, CA) from 2016 to 2021: 2 510(k) clearances. Most are in product codes QEA (Brain Injury Adjunctive Interpretive…) and GWN (Nystagmograph). Its devices cite 2 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Syncthink, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2021
2026 so far, outlined.
Recalls per year
1in 2023
Class I Class II/III not classified
Planning a device like Syncthink, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report